KRYPT
Kairos Pharma adjusts stock purchase price to 97% of VWAP
Kairos Pharma and Helena Global Investment modified a stock purchase agreement, reducing the purchase price from a fixed amount to a metric based on daily trading volume. This adjustment could impact Krypt's future drawdowns.